Cambridge Investment Research Advisors’s Omeros OMER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$879K Buy
92,403
+3,835
+4% +$45.6K ﹤0.01% 2250
2026
Q1
$935K Buy
88,568
+6,925
+8% +$81.6K ﹤0.01% 2230
2025
Q4
$1.4M Buy
81,643
+63,424
+348% +$546K ﹤0.01% 1830
2025
Q3
$75K Buy
18,219
+2,801
+18% +$11.1K ﹤0.01% 3622
2025
Q2
$46K Buy
15,418
+4,319
+39% +$21.5K ﹤0.01% 3544
2025
Q1
$91K Buy
11,099
+6
+0.1% +$53 ﹤0.01% 3361
2024
Q4
$110K Sell
11,093
-4,350
-28% -$29.9K ﹤0.01% 3318
2024
Q3
$61K Buy
15,443
+1,200
+8% +$5.12K ﹤0.01% 3318
2024
Q2
$58K Sell
14,243
-500
-3% -$1.79K ﹤0.01% 3206
2024
Q1
$51K Buy
14,743
+600
+4% +$2.28K ﹤0.01% 3210
2023
Q4
$46K Sell
14,143
-33,230
-70% -$70.2K ﹤0.01% 3103
2023
Q3
$138K Sell
47,373
-57
-0.1% -$229 ﹤0.01% 2908
2023
Q2
$258K Sell
47,430
-7,134
-13% -$41.7K ﹤0.01% 2668
2023
Q1
$254K Sell
54,564
-523
-0.9% -$1.89K ﹤0.01% 2625
2022
Q4
$124K Buy
55,087
+17,600
+47% +$48.5K ﹤0.01% 2872
2022
Q3
$118K Hold
37,487
﹤0.01% 2820
2022
Q2
$103K Buy
37,487
+9,450
+34% +$32K ﹤0.01% 2863
2022
Q1
$169K Sell
28,037
-6,547
-19% -$40.8K ﹤0.01% 2919
2021
Q4
$222K Sell
34,584
-5,210
-13% -$37.8K ﹤0.01% 2788
2021
Q3
$549K Buy
39,794
+3,847
+11% +$57.6K ﹤0.01% 1973
2021
Q2
$533K Buy
35,947
+6,000
+20% +$101K ﹤0.01% 2001
2021
Q1
$533K Sell
29,947
-6,800
-19% -$132K ﹤0.01% 1860
2020
Q4
$525K Sell
36,747
-1,370
-4% -$16.7K ﹤0.01% 1739
2020
Q3
$385K Buy
38,117
+15,730
+70% +$203K ﹤0.01% 1776
2020
Q2
$330K Sell
22,387
-1,466
-6% -$21.9K ﹤0.01% 1813
2020
Q1
$319K Buy
23,853
+5,060
+27% +$67.3K ﹤0.01% 1641
2019
Q4
$265K Buy
18,793
+3,900
+26% +$57.1K ﹤0.01% 1992
2019
Q3
$243K Sell
14,893
-4,700
-24% -$80.6K ﹤0.01% 1980
2019
Q2
$307K Buy
19,593
+1,543
+9% +$27.7K ﹤0.01% 1736
2019
Q1
$314K Buy
18,050
+800
+5% +$11.5K ﹤0.01% 1776
2018
Q4
$192K Buy
17,250
+4,150
+32% +$58.2K ﹤0.01% 1934
2018
Q3
$320K Sell
13,100
-3,395
-21% -$75.7K ﹤0.01% 1757
2018
Q2
$299K Buy
16,495
+1,700
+11% +$29.5K ﹤0.01% 1733
2018
Q1
$165K Sell
14,795
-1,950
-12% -$27.4K ﹤0.01% 2000
2017
Q4
$325K Buy
16,745
+4,900
+41% +$91.9K ﹤0.01% 1597
2017
Q3
$256K Buy
+11,845
New +$251K ﹤0.01% 1662

Other funds holding OMER

Cambridge Investment Research Advisors's OMER Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Omeros (OMER) stake by 4.3% in Q2 2026, buying an estimated $45.6K and bringing the position to 92,403 shares worth $879K. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

Cambridge Investment Research Advisors first reported a position in OMER in Q3 2017 and has held it in 36 quarters since. The position peaked at $1.4M in Q4 2025. 24 funds tracked by Wall St. Rank hold OMER as of Q2 2026.

  • Cambridge Investment Research Advisors held 92,403 shares of Omeros worth $879K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 3,835 Omeros shares in Q2 2026, an estimated $45.6K.
  • Omeros made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2250 holding.
  • Cambridge Investment Research Advisors first reported a position in Omeros in Q3 2017 and has held it in 36 quarters since.
  • Cambridge Investment Research Advisors's Omeros position peaked at $1.4M in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Omeros as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.